Andrew Reardon - 10 Aug 2024 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
10 Aug 2024
Net transactions value
-$193,839
Form type
4
Filing time
02 Jun 2025, 20:06:06 UTC
Previous filing
02 Jul 2024
Next filing
30 Aug 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reardon Andrew CLO & Secretary 555 HERITAGE DRIVE, SUITE 200, JUPITER /s/ Andrew Reardon 02 Jun 2025 0001950232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability $89,839 -897 -4% $100.16 21,637 10 Aug 2024 Direct F1
transaction LGND Common Stock Sale $104,000 -1,000 -2.9% $104.00 32,903 15 May 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
F2 The total includes 17 shares acquired on December 31, 2024, through the Issuer's Employee Stock Purchase Plan.